Eyebright Medical Technology Beijing Co Ltd
Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more
Eyebright Medical Technology Beijing Co Ltd (688050) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.026x
Based on the latest financial reports, Eyebright Medical Technology Beijing Co Ltd (688050) has a cash flow conversion efficiency ratio of 0.026x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥76.92 Million) by net assets (CN¥3.01 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Eyebright Medical Technology Beijing Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Eyebright Medical Technology Beijing Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Eyebright Medical Technology Beijing Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eyebright Medical Technology Beijing Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Integrated Cannabis Company Inc
PINK:CRPGF
|
0.000x |
|
Hainan Development Holdings Nanhai Co Ltd
SHE:002163
|
-0.084x |
|
BIRD CONSTRUCTION
F:6LT
|
N/A |
|
Grenergy Renovables S.A
MC:GRE
|
0.053x |
|
LINTEC CORP.
F:57T
|
N/A |
|
Koh Young Technology Inc
KQ:098460
|
0.000x |
|
Perpetual Ltd
AU:PPT
|
0.119x |
|
Coastal Financial Corp
NASDAQ:CCB
|
0.120x |
Annual Cash Flow Conversion Efficiency for Eyebright Medical Technology Beijing Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.63 Billion | CN¥347.75 Million | 0.132x | +37.45% |
| 2023-12-31 | CN¥2.36 Billion | CN¥226.27 Million | 0.096x | -26.27% |
| 2022-12-31 | CN¥1.92 Billion | CN¥250.13 Million | 0.130x | +3.37% |
| 2021-12-31 | CN¥1.74 Billion | CN¥219.30 Million | 0.126x | +58.11% |
| 2020-12-31 | CN¥1.55 Billion | CN¥123.35 Million | 0.080x | +2.21% |
| 2019-12-31 | CN¥647.52 Million | CN¥50.49 Million | 0.078x | +35.73% |
| 2018-12-31 | CN¥553.87 Million | CN¥31.82 Million | 0.057x | +174.70% |
| 2017-12-31 | CN¥198.44 Million | CN¥4.15 Million | 0.021x | +216.46% |
| 2016-12-31 | CN¥187.52 Million | CN¥-3.37 Million | -0.018x | -- |